-
公开(公告)号：US4101677A
公开(公告)日：1978-07-18
申请号：US806790
申请日：1977-06-15
IPC分类号： C07C217/74 , A61K31/13 , A61K31/135 , C07C67/00 , C07C213/00
CPC分类号： C07C2102/10 , Y10S514/817
摘要： Covers a compound selected from the group consisting of a member of the formula: ##STR1## wherein R.sub.1 is a radial selected from the group consisting of higher branched or straight chain alkyl and cycloalkyl radicals wherein said R.sub.1 radical contains at least six carbon atoms, R.sub.2 is a radical selected from the group consisting of hydrogen, loweralkyl and loweralkanol radicals, wherein said R.sub.2 radical contains 1 - 3 carbon atoms, and R.sub.3 is methoxy; and nontoxic pharmaceutically acceptable acid addition salts thereof. Also covers the use of said compound as a local anesthetic and pharmaceutical compositions comprising said above compounds as the active ingredient.
摘要翻译： 包括选自下列成员组成的组的化合物：其中R1是选自由较高支链或直链烷基和环烷基组成的组的放射线，其中所述R 1基团含有至少6个碳原子，R 2 是选自氢，低级烷基和低级烷醇基团的基团，其中所述R 2基团含有1-3个碳原子，并且R 3是甲氧基; 和无毒的药学上可接受的酸加成盐。 还包括所述化合物作为局部麻醉剂的用途和包含所述上述化合物作为活性成分的药物组合物。
-
2.发明授权N,N'-bis-(6-amino)-4,4-hexamethylenediamino quinaldine dihydrochloride as an anti-L-1210 lymphoid and P388 lymphocytic leukemia agent 失效N，N（40-双 - （6-氨基）-4,4-六亚甲基二氨基喹哪啶二盐酸盐作为抗L-1210淋巴和P388淋巴细胞白血病剂
公开(公告)号：US3974279A
公开(公告)日：1976-08-10
申请号：US508386
申请日：1974-09-23
IPC分类号： A61K31/47 , C07D215/46
CPC分类号： C07D215/46 , A61K31/47
摘要： A method of prolonging survival time of mammalian cancer hosts and/or ameliorating tumor growth comprising administering a therapeutically effective amount of N,N'-bis-(6-amino)-4,4-hexamethylenediamino quinaldine dihydrochloride.
摘要翻译： 一种延长哺乳动物癌症宿主的存活时间和/或改善肿瘤生长的方法，包括施用治疗有效量的N，N'-双（6-氨基）-4,4-六亚甲基二氨基喹哪啶二盐酸盐。
-
公开(公告)号：US4057582A
公开(公告)日：1977-11-08
申请号：US401018
申请日：1973-09-26
IPC分类号： C07C217/74 , A61K31/13 , A61K31/135 , C07C67/00 , C07C213/00 , C07C91/16
CPC分类号： C07C2102/10 , Y10S514/817
摘要： Covers a compound selected from the group consisting of a member of the formula: ##STR1## where R.sub.1 is a radical selected from the group consisting of higher branched or straight chain alkyl and cycloalkyl radicals wherein said R.sub.1 radical contains at least six carbon atoms, R.sub.2 is a radical selected from the group consisting of hydrogen, loweralkyl and loweralkanol radicals, wherein said R.sub.2 radical contains 1-3 carbon atoms, and R.sub.3 is methoxy; and nontoxic pharmaceutically acceptable acid addition salts thereof. Also covers the use of said compound as a local anesthetic and pharmaceutical compositions comprising said above compounds as the active ingredient.
摘要翻译： 包括选自下列成员的化合物：其中R 1是选自较高支链或直链烷基和环烷基的基团，其中所述R 1基团含有至少6个碳原子，R 2 是选自氢，低级烷基和低级烷醇基团的基团，其中所述R 2基团含有1-3个碳原子，并且R 3是甲氧基; 和无毒的药学上可接受的酸加成盐。 还包括所述化合物作为局部麻醉剂的用途和包含所述上述化合物作为活性成分的药物组合物。
-
-
搜索结果
3 条记录 (耗时 0.01 秒)
